Absence of effects of long-term growth hormone replacement therapy on insulin sensitivity in adults with growth hormone deficiency of childhood-onset (GHDA-CO)

Growth Hormone and IGF Research

Volumn 13, Issue 5, 2003, Pages 295-302

  Knoepfelmacher, Mirta ^a   Soares Jallad, Raquel ^a   Liberman, Bernardo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Body composition; Carbohydrate metabolism; Growth hormone replacement therapy; Growth hormone deficient adults of childhood onset; Insulin sensitivity; Lipid profile

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN; HUMAN GROWTH HORMONE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY COMPOSITION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MALE; MEDICAL ASSESSMENT; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0141519636     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-6374(03)00040-6     Document Type: Article

References (39)

1. T. Rosén, S. Edén, G. Larson, L. Wilhelmsen, B.-A. Bengtsson, Cardiovascular risk factors in adult patients with growth hormone deficiency, Acta Endocrinol. (Copenh.) 129 (1993) 195-200.
2. R.C. Cuneo, F. Salomon, G.F. Watts, R. Hesp, P.H. Sönksen, Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency, Metabolism 42 (1993) 1519-1523.
3. K.A.S. Al-Shoumer, K.H. Cox, C.L. Hughs, W. Richmond, D.G. Johnston, Fasting and postprandial lipids abnormalities in hypopituitary women receiving conventional replacement therapy, J. Clin. Endocrinol. Metab. 82 (1997) 2653-2659.
4. J.U. Weaver, J.P. Monson, K. Noonan, et al., The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults, J. Clin. Endocrinol. Metab. 80 (1995) 153-159.
5. Y.E.M. Snel, R.-J.M. Brummer, M.E. Doerga, et al., Adipose tissue assessed by magnetic resonance imaging in growth hormone-deficient adults: the effect of growth hormone replacement and a comparison with control subjects, Am. J. Clin. Nutr. 61 (1995) 1290-1294.
6. J.-O. Johansson, J. Fowelin, K. Landin, I. Lager, B.-A. Bengtsson, Growth hormone deficient adults are insulin resistant, Metabolism 44 (1995) 1126-1129.
7. F.L. Hew, M. Koschmann, et al., Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity, J. Clin. Endocrinol. Metab. 81 (1996) 555-564.
8. F. Salomon, R.C. Cuneo, R. Hesp, P.H. Sonksen, The effect of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency, N. Engl. J. Med. 321 (1989) 1797-1803.
9. J.O. Jörgensen, S.A. Pedersen, L. Thuesen, J. Jörgensen, T. Ingermann-Hasen, N.E. Skakkebaek, J.S. Christiansen, Beneficial effects of growth hormone treatment in GH-deficient adults, Lancet 1 (1989) 1221-1225.
10. P.R. Bratusch-Marrain, D. Smith, R.A. De Fronzo, The effect of growth hormone on glucose metabolism and insulin secretion in man, J. Clin. Endocrinol. Metab. 55 (1982) 973-982.
11. R.S. Sherwin, G.A. Scchulman, R.G. Hendler, Effect of growth hormone on oral glucose tolerance and circulating metabolic fuels in man, Diabetologia 24 (1983) 155-161.
12. A. Binnert, R.G. Swart, J.H.P. Wilson, N. Hoogerbrugge, H.A.P. Pots, J.C. Birkenhagen, S.W.J. Lamberts, The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well on body composition, Clin. Endocrinol. (Oxf.) 37 (1992) 79-87.
13. D.N. O'Neal, A. Kalfas, M.J. Christopher, S.D. Sawyer, G. Ward, F.P. Alford, The effect of 3 months of recombinant growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysis, J. Clin. Endocrinol. Metab. 79 (1994) 975-983.
14. T. Rosen, G. Johannsson, P. Hallgren, K. Caidahl, I. Bosaeues, B.A. Bengtsson, Beneficial effects of 12 months replacement therapy with recombinant growth hormone to growth hormone deficient adults, Endocrinol. Metab. 1 (1994) 55-66.
15. J. Fowelin, S. Attvall, I. Lager, B.-A. Bengtsson, Effects of treatment with recombinant growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency, Metabolism 42 (1993) 1443-1447.
16. M. Riedl, B. Ludvik, G. Pacini, et al., The increased insulin sensitivity in growth-hormone-deficient adults is reduced by growth hormone replacement therapy, Eur. J. Clin. Invest. 30 (2000) 771-778.
17. Am. Rosenfalck, S. Maghsoudi, S. Fisfer, J.O.L. Jorgensen, J.S. Christiansen, J. Hilsted, A.A. Volund, S. Madsbad, The effect of 30 months of low-dose replacement therapy with recombinant growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults, J. Clin. Endocrinol. Metab. 85 (2000) 4173-4181.
18. A. Chrisoulidou, S.A. Beshiah, O. Rutherford, T.J. Spinks, J. Mayet, P. Kyd, Anyaoku, A. Haida, AriffB, M. Murphy, E. Thomas, S. Robinson, R. Foale, D.G. Jonhston, Effect of 7 years of growth hormone replacement therapy in hypopituitary adults, J. Clin. Endocrinol. Metab. 85 (2000) 3762-3769.
19. J. Svensson, J. Fowelin, K. Landin, B.-A. Bengtsson, J.-O. Johansson, Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults, J. Clin. Endocrinol. Metab. 87 (2002) 2121-2127.
20. J. Gibney, J.D. Wallace, T. Spinks, L. Schnorr, A. Ranicar, R.C. Cuneo, S. Lockart, K.G. Burnand, F. Salomon, P.H. Sonksen, D. Russel-Jones, The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients, J. Clin. Endocrinol. Metab. 84 (1999) 2596-2602.
21. M. Matsuda, R.A. DeFronzo, Insulin sensitivity indeces obtained from oral glucose tolerance test, Diabetes Care 22 (1999) 1462-1470.
22. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.R. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man, Diabetologia 28 (1985) 412-419.
23. M. Knoepfelmacher on behalf of NordiReg Study Group, Growth hormone deficiency in adults: a comparison between treated and untreated patients, Abstract Book of 11th International Congress of Endocrinology (ICE 2000), Sydney, Australia, 2000, p.206.
24. G.W. MacDonald, G.F. Fisher, C. Burnham, Reproducibility of the glucose tolerance test, Diabetes 26 (1965) 473-480.
25. P.E. Harding, N.W. Oakley, V. Wynn, Reproducibility of glucose tolerance test data in normal and mildly diabetic subjects, Clin. Endocrinol. (Oxf.) 35 (1973) 387-395.
26. K.O. Chan, G.T. Lau, J.C. Yeung, E. Chow, G.T. Cockram, The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors, Ann. Clin. Biochem. 35 (1998) 62-67.
27. A.S. Al-Shoumer, R. Gray, V. Anyaoku, et al., Effects of four years treatment with biosynthetic human growth hormone on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults, J. Clin. Endocrinol. Metab. 48 (1998) 795-802.
28. B. Bülow, E.M. Erfurth, A low individualized dose in young patients with childhood onset GH deficiency normalized serum IGF-1 without significant deterioration in glucose tolerance, Clin. Endocrinol. (Oxf.) 50 (1) (1999) 45-55.
29. J.J. Chipman, A.F. Attanasio, M.A. Birbett, P.C. Bates, S. Webb, W.J. Lamberts, The safety profile of GH replacement therapy in adults, Clin. Endocrinol. 46 (1997) 473-481.
30. S.A. Beshiah, A. Henderson, R. Nithyanathan, E. Skinner, V. Anyaoku, W. Richmond, P. Sharp, D.G. Johnston, The effects of short and long term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance, J. Clin. Endocrinol. Metab. 80 (1995) 356-363.
31. H.M. Whitehead, C. Boreham, E.M. Mc Ilrrath, B. Sheridan, L. Kennedy, A.B. Atkison, D.R. Hadden, Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study, Clin. Endocrinol. 37 (1992) 79-87.
32. R.A. De Fronzo, Glucose intolerance and ageing: evidence for tissue insensitivity to insulin, Diabetes 28 (1979) 1095-1101.
33. M. Chen, R.N. Bergman, G. Pacini, D.J. Porte, Pathogenesis of age-related intolerance in man: insulin resistance and decreased beta-cell function, J. Clin. Endocrinol. Metab. 60 (1985) 13-20.
34. K. Yamanouchi, H. Nakajima, T. Shinozaki, K. Chikada, K. Kato, Y. Oshida, M. Higushi, Effects of daily physical activity on insulin action in the elderly, J. Appl. Physiol. 73 (1992) 2241-2245.
35. D. Elahi, Dc Muller, M. Mc Aloon-Dike, J.D. Tobin, R. Anres, The effect of age on insulin response and glucose utilization during four hypoglicemic plateau, Exp. Geront. 28 (1993) 393-409.
36. D.C. Muller, D. Elahi, J.D. Tobin, R. Andrès, Insulin response during the oral glucose tolerance test: the role of age, sex, body fat and the of fat distribution, Aging 8 (1996) 13-21.
37. P. Iozzo, H. Beck-Nielsen, M. Laakso, U. Smith, H. Ykijearvinen, E. Ferranini, Independent basal insulin secretion in non diabetic humans, J. Clin. Endocrinol. Metab. 84 (1999) 863-868.
38. K.C. Chiu, N.P. Lee, P. Cohan, L.M. Chuang, Beta-cell function declines with age in glucose tolerant caucasians, Clin. Endocrinol. 53 (2000) 569-575.
39. A.F. Attanasio, S.W.J. Lamberts, A.M.C. Matranga, Adult growth hormone-deficient adults demonstrate heterogenicity between childhood onset and adult onset before and during human GH treatment, J. Clin. Endocrinol. Metab. 82 (1997) 82-88.